The Effect of Gemcitabine on Cell Cycle Arrest and microRNA Signatures in Pancreatic Cancer Cells

Conclusion: Altered miRNAs may serve as potential therapeutic targets for improving the efficacy of gemcitabine in PDAC.

Source: In Vivo - November 3, 2020 Category: Research Authors: NAMIMA, D., FUJIHARA, S., IWAMA, H., FUJITA, K., MATSUI, T., NAKAHARA, M., OKAMURA, M., HIRATA, M., KONO, T., FUJITA, N., YAMANA, H., KATO, K., KAMADA, H., MORISHITA, A., KOBARA, H., TSUTSUI, K., MASAKI, T. Tags: Experimental Studies Source Type: research